/PRNewswire/ The epigenetics market size is expected to grow by USD 1,148.2 million during 2022-2027, progressing at a CAGR of 14.06% as per the latest.
“The kits segment accounted for the highest growth rate in the Immunofluorescence assay market, by product, during the forecast period”
The Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories. The kits segment accounted for the highest growth rate in the Immunofluorescence assay market in 2020.
“Indirect immunofluorescence segment accounted for the highest CAGR”
Based on type, the immunofluorescence assays market is segmented into indirect immunofluorescence and direct immunofluorescence. In 2020, indirect immunofluorescence accounted for accounted for the highest growth rate.
“Cancer segment accounted for the highest CAGR”
Based on disease, the immunofluorescence assays market is segmented into cancer, infectious diseases, autoimmune diseases, cardiovascular diseases, and other diseases. In 2020, the cancer segment accounted for the highest growth rate. Increasing prevalence of cancer globally an